HSIC (Henry Schein) Stock Based Compensation: $37 Mil (TTM As of Mar. 2026)


HSIC Henry Schein Inc HSIC
79 GF Score
Price $86.27
GF Value $83.79
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Henry Schein Stock Based Compensation?

Henry Schein HSIC -0.19% 79 Stock Based Compensation is $37 Mil as of Mar. 2026. GuruFocus rates HSIC with a GF Score™ of 79/100 and a GF Value™ of $83.79 (Fairly Valued). The stock has 9 warning signs investors should review.

Henry Schein's Stock Based Compensation for the three months ended in Mar. 2026 was $3 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $37 Mil.

Henry Schein Stock Based Compensation Related Terms

Henry Schein Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Henry Schein's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henry Schein Stock Based Compensation Chart

Henry Schein Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.00 54.00 39.00 39.00 39.00

Henry Schein Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 11.00 13.00 10.00 3.00
HSIC
79GF Score
Henry Schein Inc HSIC
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Henry Schein Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $37 Mil.

What does a Stock Based Compensation of $37 Mil mean?
Henry Schein (HSIC) has a Stock Based Compensation of $37 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Henry Schein and its competitors.
Is Henry Schein's Stock Based Compensation too high?
Henry Schein's current Stock Based Compensation is $37 Mil. Overall, Henry Schein has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's Stock Based Compensation compare to AHG and ACH?
Henry Schein's Stock Based Compensation of $37 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Distribution company?
A good Stock Based Compensation depends on the Medical Distribution industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Henry Schein and its competitors. Henry Schein's current Stock Based Compensation is $37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Based on GuruFocus' analysis, Henry Schein (HSIC) is currently considered Fairly Valued. The stock's GF Value™ is $83.79, compared to a current price of $86.27 — trading 3% above its estimated fair value. The current Stock Based Compensation is $37 Mil. Henry Schein's overall GF Score™ is 79/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Henry Schein (HSIC), the current Stock Based Compensation is $37 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Henry Schein (HSIC) Overvalued in 2026?

Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued. The current stock price of $86.27 is trading 3% above its estimated GF Value™ of $83.79. GuruFocus considers Henry Schein to be Fairly Valued.

Key valuation signals for HSIC:

  • Stock Based Compensation: $37 Mil
  • GF Value™: $83.79 vs. price of $86.27 (3% above fair value)
  • GF Score™: 79/100 with 9 warning signs

No single metric tells the full story. See the HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Henry Schein Business Description

Address 135 Duryea Road, Melville, NY, USA, 11747
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
79GF Score

Get the complete analysis for HSIC

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$86.27
Price
$83.79
GF Value